Prenatal Genetic Diagnosis

Avery's Diseases of the Newborn

Volumn , Issue , 2005, Pages 186-193

  Bianchi, Diana W ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349260213     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-072169347-7.50020-2     Document Type: Chapter

References (73)

1. Bakketeig LS, Eik-Neis SH, Jacobsen G, et al. Randomised controlled trial of ultrasonographic screening in pregnancy. Lancet 1984, 2:207.
2. Barela AL, Kleinman GE, Golditch IM, et al. Septic shock with renal failure after chorionic villus sampling. Am J Obstet Gynecol 1986, 154:1100.
3. Barss VA, Benacerraf BR, Frigoletto FD Antenatal sonographic diagnosis of fetal gastrointestinal malformations. Pediatrics 1985, 76:445.
4. Benacerraf BR, Gelman R, Frigoletto FD Sonographic identification of second trimester fetuses with Down's syndrome. NEngl J Med 1987, 317:1371.
5. Bergstrand CG Alpha-fetoprotein in paediatrics. Acta Paediatr Scand 1986, 75:1.
6. Bianchi DW Prenatal diagnosis by analysis of fetal cells in maternal blood. J Pediatr 1995, 127:847.
7. Bianchi DW, Flint AF, Pizzimenti MF, et al. Isolation of fetal DNA from nucleated erythrocytes in maternal blood. Proc Natl Acad Sci U S A 1990, 87:3279.
8. Bianchi DW, Wilkins-Haug LE, Enders AC, Hay ED Origin of extraembryonic mesoderm: Relevance to chorionic villus sampling. Am J Med Genet 1993, 46:542.
9. Bianchi DW, Simpson JL, Jackson LG, et al. Fetal gender and aneuploidy detection using fetal cells in maternal blood: Analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn 2002, 22:609.
10. Birnholz JC Determination of fetal sex. N Engl J Med 1983, 309:942.
11. Blakemore KJ, Mahoney MJ, Hobbins JC Infection and chorionic villus sampling. Lancet 1985, 2:338.
12. Bogart MH, Pandian MR, Hobbins JC Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 1987, 7:623.
13. Brambati B, Lanzani A, Oldrini A Transabdominal chorionic villus sampling: Clinical experience of 1,159 cases. Prenat Diagn 1988, 8:609.
14. Brambati B, Tului L, Shrimanker K, et al. Serum PAPP-A and free β-hCG are first-trimester screening markers for Down syndrome. Prenat Diagn 1994, 14:1043.
15. Brock DJH, Sutcliffe RG Alpha fetoprotein in the antenatal diagnosis of anencephaly and spina bifida. Lancet 1972, 2:197.
16. Burton BK, Dillard RG Outcome in infants born to mothers with unexplained elevations of maternal serum alpha fetoprotein. Pediatrics 1986, 77:582.
17. Burton BK, Schulz CJ, Burd LI Limb anomalies associated with chorionic villus sampling. Obstet Gynecol 1992, 79:726.
18. Burton BK, Schulz CJ, Angle B, et al. An increased incidence of haemangiomas in infants born following chorionic villus sampling (CVS). Prenat Diagn 1995, 15:209.
19. Campbell S, Pearce JM Ultrasound visualization of congenital malformations. Br Med Bull 1983, 39:322.
20. Chervenak FA, Isaacson G, Blakemore KJ Fetal cystic hygroma: Cause and natural history. N Engl J Med 1983, 309:822.
21. Recommendations for prenatal counseling. Centers for Disease Control and Prevention. MMWR Recomm Rep 1995, 44RR-9:1. Chorionic villus sampling and amniocentesis.
22. Cicero S, Curcio P, Papgeorghiou A, et al. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: An observational study. Lancet 2001, 358:1658.
23. Crandall BF Alpha-fetoprotein: The diagnosis of neural tube defects. Pediatr Ann 1981, 10:38.
24. Crandall BF, Robertson RD, Lebherz TB Maternal serum alpha-fetoprotein screening for the detection of neural tube defects. West J Med 1983, 138:524.
25. Crane JP, LeFevre ML, Winborn RC A randomized trial of prenatal ultrasonographic screening: Impact on the detection, management, and outcome of anomalous fetuses. Am J Obstet Gynecol 1994, 171:392.
26. Daffos F, Capella-Pavlovsky M, Forestier F Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: A study of 606 consecutive cases. Am J Obstet Gynecol 1985, 153:655.
27. de la Cruz F, Shifrin H, Elias S, et al. Prenatal diagnosis by use of fetal cells isolated from maternal blood. Am J Obstet Gynecol 1995, 173:1354.
28. Dimaio MS, Baumgarten A, Greenstein RM, et al. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha fetoprotein levels. N Engl J Med 1987, 317:342.
29. Eik-Neis SH, Okland O, Aure JC, et al. Ultrasound screening in pregnancy: A randomised controlled trial. Lancet 1984, 1:1347.
30. Elejalde BR, Elejalde MM The prenatal growth of the human body determined by the measurement of bones and organs by ultrasonography. Am J Med Genet 1986, 24:575.
31. Ewigman BG, Crane JP, Frigoletto FD, et al. Effect of prenatal ultrasound screening on perinatal outcome. RADIUS Study Group. N Engl J Med 1993, 329:821.
32. Farrell SA, Summers AM, Dallaire L, et al. Club foot, an adverse outcome of early amniocentesis: Disruption or deformation? CEMAT. Canadian Early and Mid-Trimester Amniocentesis Trial. J Med Genet 1999, 36:843.
33. Ferguson-Smith MA The reduction of anencephalic and spina bifida births by maternal serum alpha-fetoprotein screening. Br Med Bull 1983, 39:365.
34. Firth HV, Boyd PA, Chamberlain PF, et al. Limb abnormalities and chorionic villus sampling. Lancet 1991, 338:51.
35. Firth HV, Chamberlain PF, MacKenzie IZ, et al. Analyses of limb reduction defects in babies exposed to chorionic villus sampling. Lancet 1994, 343:1069.
36. Fletcher JC, Evans MI Maternal bonding in early fetal ultrasound examinations. N Engl J Med 1983, 308:392.
37. Forestier F, Cox WJ, Daffos F, et al. The assessment of fetal blood samples. Am J Obstet Gynecol 1988, 158:1184.
38. Golbus MS, Longman WD, Epstein CJ, et al. Prenatal genetic diagnosis in 3,000 amniocenteses. N Engl J Med 1979, 300:157.
39. Gosden C, Nicolaides KH, Rodeck CH Fetal blood sampling in investigation of chromosome mosaicism in amniotic fluid cell culture. Lancet 1988, 1:613.
40. Gosden CM Amniotic fluid cell types and culture. Br Med Bull 1983, 39:348.
41. Griffiths DM, Gough MH Dilemmas after ultrasonographic diagnosis of fetal abnormality. Lancet 1985, 1:623.
42. Haddow JE, Palomaki GE, Knight GJ, et al. Screening of maternal serum for fetal Down's syndrome in the first trimester. NEngl J Med 1998, 338:955.
43. Handyside AH, Lesko JG, Tar'n JJ, et al. Birth of a normal girl after in vitro fertilization and preimplantation diagnostic testing for cystic fibrosis. N Engl J Med 1992, 327:905.
44. Harper J Preimplantation diagnosis of inherited disease by embryo biopsy: An update of the world figures. J Assist Reprod Genet 1996, 13:90.
45. Harper J, Wells D Recent advances and further developments in PGD. Prenat Diagn 1999, 19:1193.
46. Hill LM, Breckle R, Gehrking WC The prenatal detection of congenital malformations by ultrasonography. Mayo Clin Proc 1983, 58:805.
47. Hogge WA, Schonberg SA, Golbus MS Chorionic villus sampling: Experience of the first 1,000 cases. Am J Obstet Gynecol 1986, 154:1249.
48. Hsieh F-J, Shyu M-K, Sheu B-C, et al. Limb defects after chorionic villus sampling. Obstet Gynecol 1995, 85:84.
49. Hyett J, Moscoso G, Papanagiotou G, et al. Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 1996, 7:245.
50. Jackson LG First trimester diagnosis of fetal genetic disorders. Hosp Pract (Off Ed) 1985, 20:39.
51. Johansen M, Knight M, Maher EJ, et al. An investigation of methods for enriching trophoblast from maternal blood. Prenat Diagn 1995, 15:921.
52. Kazy Z, Rozovsky IS, Bakharev VA Chorion biopsy in early pregnancy: A method of early prenatal diagnosis for inherited disorders. Prenat Diagn 1982, 2:39.
53. Ledbetter DH, Zachary JM, Simpson JL, et al. Cytogenetic results from the U. S. Collaborative Study on CVS. Prenat Diagn 1992, 12:317-345.
54. Librach CL, Hogdall CK, Doran TA Weights of fetuses with autosomal trisomies at termination of pregnancy: An investigation of the etiologic factors of low serum alpha-fetoprotein values. Am J Obstet Gynecol 1988, 158:290.
55. Lo YMD, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997, 350:485.
56. Merkatz IR, Nitowsky HM, Macri JN, et al. An association between low maternal serum alpha-fetoprotein and fetal chromosome abnormalities. Am J Obstet Gynecol 1984, 148:886.
57. Nelson K, Holmes LB Malformations due to presumed spontaneous mutations in newborn infants. N Engl J Med 1989, 320:19.
58. Norton ME Biochemical and ultrasound screening for chromosomal abnormalities. Semin Perinat 1994, 18:256.
59. Palomaki GE, Haddow JE Maternal serum alpha-fetoprotein, age, and Down syndrome risk. Am J Obstet Gynecol 1987, 156:460.
60. Pertl B, Bianchi DW Fetal DNA in maternal plasma: Emerging clinical applications. Obstet Gynecol 2001, 98:483.
61. Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis. Canadian Early and Mid-Trimester Amniocentesis Trial (CEMAT) Group. Lancet 1998, 351:242.
62. Rhoads G, Jackson L, Schlesselman S, et al. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J Med 1989, 320:609.
63. Rose NC, Mennuti MT Maternal serum screening for neural tube defects and fetal chromosome abnormalities. West J Med 1993, 159:312.
64. Rutledge JC, Weinberg AG, Friedman JM Anatomic correlatesof ultrasonographic prenatal diagnosis. Prenat Diagn 1986, 6:51.
65. Sabbagha RE, Sheikh Z, Tamura R, et al. Predictive value, sensitivity, and specificity of ultrasonic targeted imaging for fetal anomalies in gravid women at high risk for birth defects. Am J Obstet Gynecol 1985, 152:822.
66. Saul RA, Stevenson RE, Rogers RC, et al: Growth references from conception to adulthood. Proceedings of the Greenwood Genetics Center, Greenwood, SC, (Suppl 1): pp 1-214, 1988.
67. Silverman NS, Sullivan MW, Jungkind DL, et al. Incidence of bacteremia associated with chorionic villus sampling. Obstet Gynecol 1994, 84:1021.
68. Simpson JL, Elias S Isolating fetal cells from maternal blood: Advances in prenatal diagnosis through molecular technology. JAMA 1993, 270:2357.
69. Simpson NE, Dallaire L, Miller JR, et al. Prenatal diagnosis of genetic disease in Canada: Report of a collaborative study. Can Med Assoc J 1976, 115:739.
70. Snijders RJ, Noble P, Sebire N, et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998, 351:343.
71. Midtrimester amniocentesis for prenatal diagnosis: Safety and accuracy. JAMA 1976, 236:1471. U.S. National Institutes of Health. National Institute of Child Health and Human Development (NICHHD) National Registry for Amniocentisis Study Group.
72. Verjaal M, Leschot NJ Risk of amniocentesis and laboratory findings in a series of 1,500 prenatal diagnoses. Prenat Diagn 1981, 1:173.
73. Wenstrom KD, Owen J, Chu DC, Boots L Prospective evaluation of free β subunit of human chorionic gonadotropin and dimeric inhibin A for aneuploidy detection. Am J Obstet Gynecol 1999, 181:887.